Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer

Tissue markers may be helpful in enhancing prediction of radiation therapy (RT) failure of prostate cancer (PCa). Among the various biomarkers tested in Phase III randomized trials conducted by the Radiation Therapy Oncology Group, p16, Ki-67, MDM2, COX-2, and PKA yielded the most robust data in pre...

Full description

Saved in:
Bibliographic Details
Main Author: Helmut Bonkhoff
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Prostate Cancer
Online Access:http://dx.doi.org/10.1155/2012/593241
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554180203511808
author Helmut Bonkhoff
author_facet Helmut Bonkhoff
author_sort Helmut Bonkhoff
collection DOAJ
description Tissue markers may be helpful in enhancing prediction of radiation therapy (RT) failure of prostate cancer (PCa). Among the various biomarkers tested in Phase III randomized trials conducted by the Radiation Therapy Oncology Group, p16, Ki-67, MDM2, COX-2, and PKA yielded the most robust data in predicting RT failure. Other pathways involved in RT failure are also implicated in the development of castration-resistant PCa, including the hypersensitive androgen receptor, EGFR, VEGF-R, and PI3K/Akt. Most of them are detectable in PCa tissue even at the time of initial diagnosis. Emerging evidence suggests that RT failure of PCa results from a multifactorial and heterogeneous disease process. A number of tissue markers are available to identify patients at high risk to fail RT. Some of these markers have the promise to be targeted by drugs currently available to enhance the efficacy of RT and delay disease progression.
format Article
id doaj-art-cdc8a2aa15ac407bb51e2643a3de1f10
institution Kabale University
issn 2090-3111
2090-312X
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Prostate Cancer
spelling doaj-art-cdc8a2aa15ac407bb51e2643a3de1f102025-02-03T05:52:18ZengWileyProstate Cancer2090-31112090-312X2012-01-01201210.1155/2012/593241593241Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate CancerHelmut Bonkhoff0Pathology Laboratory, Großbeerenstraße 12, 12209 Berlin, GermanyTissue markers may be helpful in enhancing prediction of radiation therapy (RT) failure of prostate cancer (PCa). Among the various biomarkers tested in Phase III randomized trials conducted by the Radiation Therapy Oncology Group, p16, Ki-67, MDM2, COX-2, and PKA yielded the most robust data in predicting RT failure. Other pathways involved in RT failure are also implicated in the development of castration-resistant PCa, including the hypersensitive androgen receptor, EGFR, VEGF-R, and PI3K/Akt. Most of them are detectable in PCa tissue even at the time of initial diagnosis. Emerging evidence suggests that RT failure of PCa results from a multifactorial and heterogeneous disease process. A number of tissue markers are available to identify patients at high risk to fail RT. Some of these markers have the promise to be targeted by drugs currently available to enhance the efficacy of RT and delay disease progression.http://dx.doi.org/10.1155/2012/593241
spellingShingle Helmut Bonkhoff
Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer
Prostate Cancer
title Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer
title_full Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer
title_fullStr Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer
title_full_unstemmed Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer
title_short Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer
title_sort factors implicated in radiation therapy failure and radiosensitization of prostate cancer
url http://dx.doi.org/10.1155/2012/593241
work_keys_str_mv AT helmutbonkhoff factorsimplicatedinradiationtherapyfailureandradiosensitizationofprostatecancer